|VADASKERT Child and Adolescent Psychiatry Hospital and Outpatient Clinic|
|Lipotmezei str 5|
Dr Julia Gadoros, PhD
|Dr Andrea Biro, local study coordinator, specialist in child and adolescent psychiatry|
|Jozsef Dotzi, deputy study coordinator|
Noemi Nyitrai, local project manager
|Margit Kovacs, lead nurse|
Dr Jozsef Halasz PhD, research clinician, specialist in child and adolescent psychiatry
Dr Peter Garas, research clinician, trainee in child and adolescent psychiatry
Dr Adrienn Nemeth, research clinician, trainee in child and adolescent psychiatry
Dr Gergely Meszaros, research clinician, specialist registrar in child and adolescent psychiatry
Description of the organization
Vadaskert Child Psychiatry Hospital and Outpatient Clinic is one of the leading Institutes of Hungarian child and adolescent psychiatry. To date, it is the only foundation owned institute in Hungary specialized in the treatment and intervention of mental disorders in children. Since its founding in 1993, more than 34,000 patients with different mental disorders and from different geographical origins within Hungary have been treated. With regard to the patients, the hospital manages approximately 5 to 10 new patients with ADHD a week and about 500 patients taking ADHD medication with regular checkups. In addition to the clinical work, the Vadaskert Child Psychiatry Hospital is a highly respected research and educational centre.
The Institution has several research projects with national and international collaborations (the Semmelweis University, Budapest, Hungary; the Eötvös Lóránd University, Faculty of Education and Psychology, Budapest, Hungary; the Central European University, Budapest, Hungary; the University of Szeged, Hungary; The University of Debrecen, Hungary; the Medical School of the University of Pittsburgh, USA; Yale University, USA and the Karolinska Institute, Stockholm, Sweden) in different fields of child and adolescent psychiatry (depression, bipolar disorder, suicide, Tourette Syndrome, obsessive‐compulsive disorder, autism and ADHD).
Profile of staff members
The clinical and research teams comprise 7 child and adolescent psychiatrists, 8 psychologists and 6 special teachers.
Dr. Julia Gadoros (MD, PhD) is the founder and Medical Director of Vadaskert Child Psychiatry Hospital and Outpatient Clinic, one of the leading Institutes of Hungarian Child Psychiatry and is a specialist in psychiatry, child and adolescent psychiatry and psychotherapy. As the Scientific and Medical Director of the Institute, she is heavily involved in both current research and everyday patient care. She has more than 100 peer reviewed papers in Hungarian and international journals, and has published several book chapters. Her main interest is the analysis of risk factors in adolescents with ADHD and related psychiatric conditions.
Judit Balázs (MD, PhD) is the Head of a Research Team of Vadaskert Research Center, and also a Senior Clinical Child Psychiatrist in the Vadaskert Child and Adolescent Psychiatric Hospital and Outpatient Clinic. At the same time she is the Head of the Department of Developmental and Clinical Child Psychology of Institute Psychology Eotvos Lorand University, Budapest. She is tutor at the Doctoral School of the Semmelweis University, Budapest. Her main interests are: ADHD, adolescent risk behaviors and suicide prevention. She is the first author of the Hungarian Guidelines on ADHD. She is the first author of several peer reviewed papers. She is currently the Hungarian partner Principal Investigator of two EU sponsored collaborative projects coordinated by the Karolinska Institute, and she just completed a third one.
Main tasks in the project
This partner will contribute to patient and control group recruitment of WP3 and WP8.
The fifth ADDUCE Newsletter is now available!
Here, you can read about the finalisation of the project,
the European Medicines Agency and General Assembly meetings
and the dissemination of the results!
The fourth ADDUCE Newsletter is available!
In this newsletter, you can find some information on the final recruitment status of the 2 main studies:
- the prospective open-label methylphenidate pharmacovigilance study
- the long-term cardiascular effects of methylphenidate use
Also, you can read about the future plans of the project!
More than 1500 children, adolescents and adults across all Europe already took part in our study! Thanks to them, we have already gathered lots of information so we can know a lot more about methylphenidate than ever before!
Did you participate in the ADDUCE studies and are you curious about the latest news on the project?
Here you can find some information!
News for children, April 2015
News for adolescents, April 2015
News for parents, April 2015
The third ADDUCE Newsletter is available!
- the prospective open-label methylphenidate pharmacovigilance study: recruitment status and spin-
- the long-term cardiovascular effects of methylphenidate use: study design and participation
and much more in the ADDUCE Newsletter 3, March 2015
WP3: prospective open-label methylphenidate
- WP8: long-term cardiovascular effects of methylphenidate use
and much more in the ADDUCE Newsletter 2, February 2013
16 - 19 OCTOBER 2016:
4rd EUNETHYDIS International Conference on ADHD, Berlin - Germany
from basis neuroscience to optimised clinical care
17 & 18 APRIL 2016:
ADDUCE Consortium meeting, London - UK
28 - 31 MAY 2015:
5th World Congress on ADHD: from Child to Adult Disorder, Glasgow - Scotland
20 & 21 APRIL 2015:
ADDUCE Consortium meeting, Salina - Italy
21 - 24 MAY 2014:
3rd EUNETHYDIS International Conference on ADHD, Istanbul - Turkey
ADHD and related disorders
19 & 20 MAY 2014:
ADDUCE Consortium meeting, Istanbul - Turkey
3 - 6 OCTOBER 2013:
23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders
6 - 9 JUNE 2013:
4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy
4 & 5 JUNE 2013:
ADDUCE Consortium meeting, Milan - Italy
6 & 7 JUNE 2012:
ADDUCE Consortium meeting, Cagliari - Italy
23 MAY 2012:
2nd EUNETHYDIS International Conference on ADHD, Barcelona - Spain